Given ACTA’s and CT:IQs complementary clinical trials sector-boosting focus, and that ACTA is a CT:IQ founding partner, and that CT:IQ held its launch symposium at ACTA’s Trial of the Year awards event, the ACTA Central Team were never going to say “no” to CT:IQ’s newly appointed Program Director, Leanne Weekes, when she asked if she could co-locate at ACTA’s new offices in South Melbourne!
CT:IQ is modelled on the highly successful US FDA-funded Clinical Trials Transformation Initiative (CTTI). It is co-funded by MTPConnect and ACTA is one of the foundation partners along with Bellberry. CT:IQ is working to advance projects spanning the clinical trials sector – commercial and investigator-initiated – that are distinct from ACTA’s work supporting clinical trials networks, coordinating centres, and registries.
Leanne would like to thank the ACTA Central Team for making her feel so welcome!
Stay in touch with CT:IQ by signing-up for its newsletter.